SAN
FRANCISCO, March 14, 2023 /PRNewswire/ -- Schubert
Jonckheer & Kolbe LLP is investigating potential derivative
claims on behalf of shareholders of Axsome Therapeutics, Inc.
(NASDAQ: AXSM) relating to securities law violations and unlawful
business practices.
Axsome Therapeutics is a biopharmaceutical manufacturer that
develops therapies for central nervous system disorders. Axsome is
currently named in a securities class action lawsuit filed in the
U.S. District Court for the Southern District of New York, in which the plaintiffs allege that
(a) Axsome's chemistry, manufacturing, and controls (CMC) processes
with their AXS-07 manufacturing were deficient; (b) because of the
deficiencies, Axsome was unable to file its AXS-07 New Drug
Application ("NDA") in its originally published timeline; (c) the
foregoing CMC issues remained in existence at the time the U.S.
Food and Drug Administration ("FDA") reviewed the AXS-07 NDA; (c)
the FDA was therefore never likely to approve the AXS-07 NDA; (d)
as a result, Axsome has overstated AXS-07's regulatory and
commercial capabilities; and (e) accordingly, Axsome's positive
statements to the market were materially false and misleading.
The Schubert Firm is investigating potential breaches of
fiduciary duty by Axsome's officers and directors in connection
with these allegations.
If you own stock in Axsome and wish to obtain additional
information about your legal rights, please contact us today or
visit our website
at https://www.classactionlawyers.com/axsome.
About Schubert Jonckheer & Kolbe LLP
Schubert
Jonckheer & Kolbe represents shareholders, employees, and
consumers in class actions against corporate defendants, as well as
shareholders in derivative actions against their officers and
directors. The firm is based in San
Francisco, and with the help of co-counsel, litigates cases
nationwide.
SOURCE: Schubert Jonckheer & Kolbe LLP
View original
content:https://www.prnewswire.com/news-releases/shareholder-alert-axsome-therapeutics-inc-axsm-officers-and-directors-face-shareholder-investigation-for-alleged-securities-law-violations-301769723.html
SOURCE Schubert Jonckheer & Kolbe LLP